Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection

NCT02237859 is registered in ClinicalTrials.gov with Corewell Health West as lead sponsor.

NCT NCT02237859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02237859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection
Lead sponsor
Corewell Health West
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2014
Completion date
August 31, 2016
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection